Volume | 3 |
|
|||||
News | - | ||||||
Day High | Low High |
||||||
Day Low |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Context Therapeutics Inc | CNTX | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
1.94 |
Trades | Shares Traded | Average Volume | 52 Week Range |
---|---|---|---|
2 | 3 | - | 0.77 - 2.24 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
07:03:52 | 2 | US$ 1.92 | USD |
Context Therapeutics Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
30.97M | 15.97M | - | 0 | -23.96M | -1.50 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Context Therapeutics News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CNTX Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 1.94 | 2.24 | 1.86 | 2.00 | 213,646 | 0.00 | 0.00% |
1 Month | 2.00 | 2.24 | 1.352 | 1.95 | 174,524 | -0.06 | -3.00% |
3 Months | 1.30 | 2.24 | 1.1999 | 1.76 | 638,064 | 0.64 | 49.23% |
6 Months | 1.08 | 2.24 | 0.89 | 1.70 | 326,115 | 0.86 | 79.63% |
1 Year | 1.29 | 2.24 | 0.77 | 1.65 | 182,279 | 0.65 | 50.39% |
3 Years | 4.44 | 10.87 | 0.47 | 3.80 | 834,134 | -2.50 | -56.31% |
5 Years | 4.44 | 10.87 | 0.47 | 3.80 | 834,134 | -2.50 | -56.31% |
Context Therapeutics Description
Context Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to improving the lives of women living with cancer. The development team is advancing a pipeline of innovative therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. |